Senseonics (NYSE:SENS) Earns Sell Rating from Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Senseonics (NYSE:SENSGet Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock.

Senseonics Trading Down 2.7 %

Senseonics stock opened at $0.41 on Friday. The company has a debt-to-equity ratio of 1.79, a quick ratio of 3.70 and a current ratio of 3.96. Senseonics has a 1 year low of $0.38 and a 1 year high of $1.05. The firm’s 50-day moving average is $0.46 and its 200-day moving average is $0.55. The company has a market cap of $217.66 million, a P/E ratio of -2.93 and a beta of 0.82.

Senseonics (NYSE:SENSGet Free Report) last issued its earnings results on Monday, May 13th. The company reported ($0.03) EPS for the quarter, meeting analysts’ consensus estimates of ($0.03). The company had revenue of $5.05 million during the quarter, compared to the consensus estimate of $4.76 million. Senseonics had a negative return on equity of 202.32% and a negative net margin of 346.38%. On average, equities analysts expect that Senseonics will post -0.13 earnings per share for the current year.

Hedge Funds Weigh In On Senseonics

Hedge funds and other institutional investors have recently modified their holdings of the company. Virtu Financial LLC bought a new position in Senseonics in the 1st quarter worth about $162,000. Price T Rowe Associates Inc. MD grew its stake in shares of Senseonics by 16.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after purchasing an additional 51,000 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Senseonics by 0.7% during the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after purchasing an additional 155,715 shares during the period. State Board of Administration of Florida Retirement System bought a new stake in shares of Senseonics during the first quarter valued at about $91,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in Senseonics by 30.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock worth $483,000 after purchasing an additional 211,128 shares during the period. Institutional investors and hedge funds own 12.36% of the company’s stock.

About Senseonics

(Get Free Report)

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.

Featured Stories

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.